Share on StockTwits

Vitamin Shoppe (NYSE:VSI) was downgraded by William Blair from an “outperform” rating to a “market perform” rating in a research note issued on Thursday, reports.

In other Vitamin Shoppe news, CEO Anthony Truesdale sold 35,000 shares of the stock on the open market in a transaction dated Friday, January 10th. The stock was sold at an average price of $48.51, for a total transaction of $1,697,850.00. Following the sale, the chief executive officer now directly owns 107,447 shares in the company, valued at approximately $5,212,254. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

A number of other analysts have also recently weighed in on VSI. Analysts at Goldman Sachs Group Inc. upgraded shares of Vitamin Shoppe from a “buy” rating to a “conviction-buy” rating in a research note to investors on Monday, November 18th. They now have a $65.00 price target on the stock, up previously from $59.00. Separately, analysts at Jefferies Group reiterated a “hold” rating on shares of Vitamin Shoppe in a research note to investors on Wednesday, November 6th. They now have a $42.00 price target on the stock. Finally, analysts at Deutsche Bank raised their price target on shares of Vitamin Shoppe from $52.00 to $55.00 in a research note to investors on Wednesday, November 6th. They now have a “buy” rating on the stock. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating, eight have given a buy rating and one has issued a strong buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $53.35.

Shares of Vitamin Shoppe (NYSE:VSI) traded down 5.11% on Thursday, hitting $46.24. 1,066,399 shares of the company’s stock traded hands. Vitamin Shoppe has a 52-week low of $39.92 and a 52-week high of $65.93. The stock has a 50-day moving average of $50.94 and a 200-day moving average of $47.15. The company has a market cap of $1.388 billion and a P/E ratio of 22.95.

Vitamin Shoppe (NYSE:VSI) last posted its quarterly earnings results on Tuesday, November 5th. The company reported $0.53 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.52 by $0.01. The company had revenue of $272.50 million for the quarter, compared to the consensus estimate of $273.87 million. During the same quarter in the previous year, the company posted $0.54 earnings per share. The company’s revenue for the quarter was up 14.0% on a year-over-year basis. On average, analysts predict that Vitamin Shoppe will post $2.28 earnings per share for the current fiscal year.

Vitamin Shoppe, Inc is a specialty retailer and direct marketer of vitamins, minerals, herbs, specialty supplements, sports nutrition and other health and wellness products.

The Fly On The Wall

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.